DatasetName,RHBDF1_S(11) RHBDF1_S(176) RHBDF1_S(3) RHBDF1_S(390) RHBDF1_S(51) RHBDF1_S(60) RHBDF1_S(61) RHBDF1_S(76) RHBDF1_S(8) RHBDF1_S(92) RHBDF1_T(183) RHBDF1_T(302),RHBDF1_S(105) RHBDF1_S(283) RHBDF1_S(346) RHBDF1_S(5) RHBDF1_T(180) RHBDF1_T(347) RHBDF1_T(85),RHBDF1_S(240) RHBDF1_S(245) RHBDF1_S(7) RHBDF1_T(75)
RM2024_Intensity D4-1___3,0.5318611163464889,,
RB2022_4_PostEndurance,0.5144399222256765,,
FSO2013_Ratio M/L normalized Rep3,0.5902639558804311,0.44914281391939737,
SR2019_MCF7_Biol_repl_3,0.5352589389805953,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,0.5347393834469726,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,0.5265234002512306,0.4310264830493743,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,0.5481441142273739,,
HS2024_6_B_T3,0.49664108312156,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,0.5425006900081316,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,0.48863616636554846,0.43512139869345223,
SR2019_MDAMB231_Biol_repl_4,0.535765550493417,,
GF2025_P2_Sph,0.5544073606822719,0.4248006526110646,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,,,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,0.5683214172370962,,
FSO2013_Ratio M/L normalized Rep1___1,0.5048767717074435,0.43551816917028036,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,0.5298897317709966,,
RM2024_Intensity D6-1,0.5433689942976739,,
RB2022_8_RecoverySprint,0.5152160569573591,,
RB2022_5_PreEndurance,0.5245819761526744,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,0.5040409636401822,,
WZ2023_Pu_010_30min,0.5210439222833699,0.43524424495609165,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,0.506479788024203,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,0.5259352075787173,0.4390559112434569,
RB2022_8_RecoveryEndurance,0.5232572108551385,,
KBE2022_Log2_Ex_14_U,,0.4315883381386095,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,,,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,0.5250526485095738,,
RB2022_5_PreSprint,0.5165821522075037,,
PG2020_Intensity 8h_C,,,
AH2018_SILAC_MR_2_N,0.5364743313726785,0.4501376433621657,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,0.5470657589291371,,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,0.5381436644836576,,
FSO2013_Ratio H/L normalized Rep2___2,0.5189331214942137,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5482234376109415,,
RM2024_Intensity D4-3___3,0.5395402518182575,,
RB2022_5_PreStrength,,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,0.5406445086165058,,
GF2025_P6_Sph,0.6130459095755836,0.48714364929763265,
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,0.5488108340672628,,
RM2024_Intensity D6-2___3,0.5401990045038533,,
WZ2023_Pe_025_10min,0.5232965240695545,0.4467959212358993,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,,,
KBE2022_Log2_Ex_34_U,,,
WZ2023_Pu_005_10min,0.5264671383695194,0.44736665109056967,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.5267683804430184,0.4394485450398244,
AH2018_SILAC_MR_2_X,0.5361711477682143,0.42580001552372027,
HS2024_4_PD_T2,0.49685852347781306,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,,,
FR2021_Norm.Intensity.B,0.527674166104576,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,0.521087996047842,,
EJN2021_3_Rest_Basal,0.5245805112986458,,
CR2017_Ratio Replicate 1.3,,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,0.5249842258627672,0.42864330402315914,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,0.5371869226276186,0.4426908166236763,
HS2024_7_PD_T2,0.5314410732291819,,
FSO2013_Ratio H/L normalized Rep1___1,0.508821039366828,0.47090295909128793,
AH2018_LFQ_1_C,0.5239220980837586,0.4339786708897498,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,0.5219505068735928,,
HS2024_3_B_N1,0.5526966644308517,,
RM2024_Intensity D4-2___3,0.5392702095353223,,
WZ2023_Pe_025_30min,0.5243331930187801,0.4434922000194615,
CK2022_11 40-1,,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,0.534569960809868,0.44285249922829545,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,,,
FSO2013_Ratio H/L normalized Rep2,0.499779762739446,0.40586534520137574,
WZ2023_Pu_005_20min,0.525968081095989,0.425567872604797,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,0.5212325177541475,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,0.5144121206324165,0.4403540623421653,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,0.5423492511658786,,
HS2024_9_B_T2,0.5323627426727454,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,0.5632149832327367,,0.6290359182410337
FSO2013_Ratio M/L normalized Rep3___2,0.5602947452619363,,
SR2019_BT549_Biol_repl_3,0.5253928903840664,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,0.5123434231799769,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,0.5062576907971365,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,,,
CK2022_1 200-1,0.5240853187079951,,
PG2020_Intensity Mock_10h_D,,,
SR2019_MCF10A_Biol_repl_2,0.5440301240032389,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,0.514231360708859,,0.7308085740944812
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5214974520896342,,
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,,,
PG2020_Intensity 2h_C,,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,0.5495405961787326,,
KBE2022_Log2_Ex_8_T,,0.43209231203954274,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,0.5292235888125735,,0.6336073398007765
RN2012_L11,0.5491533561619224,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,0.5419339085251297,,
HS2024_5_PD_T1,0.5355989352479338,0.4522653077526823,
AH2018_LFQ_M_2_C,0.5095723519724686,0.41620458870304683,
CK2022_3 40-1,,,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,0.5155141690624008,,
YA2020_Reporter_intensity_Cancer_No.5,,0.4372233560941208,
HH2022_Reporter intensity 8,,0.436891513894272,
ZQ2022_N2,0.5313116775508834,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,,,
EJN2021_5_Rest_Basal,0.5203656303184421,,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,0.5168677110525303,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,0.524413406801998,0.4249550259446078,
YA2020_Reporter_intensity_Normal_No.1,,0.4364057969428436,
HS2024_3_B_T1,0.5024171297950845,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,0.5339068094885699,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,0.5570694934337809,,
RB2022_1_PostEndurance,0.5396048484260362,,
CR2017_Ratio Replicate 3,,,
SR2019_Hs578T_Biol_repl_3,0.5322725316657217,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,0.5457927504263548,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,0.5719157048614406,0.4809172095668742,
HS2024_8_I_T3,0.5509604943791266,0.43546968114288476,
CF2017_EOC 3,0.5158260301054363,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,0.5181302894238679,,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.5244760369524553,0.44106436255576387,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,,,
KS2014_Intensity N3,,,
RB2022_4_RecoveryEndurance,0.5219036782578292,,
RB2022_5_RecoveryEndurance,0.5278763621187582,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,0.5272210500571692,0.4412390759917496,
FSO2013_Ratio H/M normalized Rep2,0.5697676393213228,0.3668434611296788,
RAM2015_Log2 A,,,
HS2024_8_PD_T1,0.5455561171123153,0.4358260495849346,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,0.5407040650312606,,
KS2014_Intensity E15_2,,,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,,,
HS2024_7_I_T1,0.5262502433297429,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,0.5282852021400463,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,0.5025755225919496,,
AH2018_SILAC_M_3_X,0.5259298359026284,0.430840783093466,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,0.5193613193486736,,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,0.4322875529754372,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,0.5318643228325403,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,0.5032872435216963,,
HS2024_6_B_N1,0.527246453970406,,
KBE2022_Log2_Ex_27_T,0.5185345781635649,0.4327565114688422,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.529302404674649,,0.6584337899154697
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,0.5245283375188173,,
AH2018_SILAC_IT_3_X,0.543752703666673,0.4464331066312336,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,,,
FSO2013_Ratio M/L normalized Rep2,0.5899149878973979,0.4324039874589368,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,,0.4441450766880874,
SR2019_HCC1954_Biol_repl_2,0.5409683791013029,,
CK2022_14 40-1,,,
RB2022_6_PreSprint,,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,,0.43741848342430983,
DL2023_control-1,,,
AR2021_ALG 10 μM,0.5190249358905802,,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,0.5198652830559626,0.4313585782856811,
EJN2021_4_Rest_Ins,0.5266592838417802,,
RN2012_H05,0.5222124338881977,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,0.5028374160328931,0.4359305384486647,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,0.5241602110833338,,
EJN2021_1_Rest_Ins,0.5281716819518224,,
HH2022_Reporter intensity 3,,0.4304958376897647,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,0.528157587644659,0.4280492199532474,
JW2021_After_3,,,
GF2025_P8_Sph,0.5633601995480055,0.4287826082292515,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,0.5369154493990556,0.4419708598704869,
CK2022_11 200-1,0.5235820359701034,,
CK2022_12 200-1,0.5237450907666442,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,0.521594330192157,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,,0.43472926209403734,
WZ2023_Su_010_20min,0.5258764052727138,0.4172681002151837,
AH2018_TMTMS2_2_N,,,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.5334631650583936,,0.6685150826135363
AH2018_TMTMS3_Pool,,,
KS2014_Intensity N4,,,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,0.5238269233811691,,
CK2022_14 200-1,0.5198525324623583,,
SR2019_Hs578T_Biol_repl_1,0.5307039259109049,,
RB2022_7_PostSprint,0.5665297503140304,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,,,
AST2020_anti-CD3+PDL2.2,,,
PG2020_Intensity Mock_10h_A,,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,0.5311465165643914,,
SR2019_LM2_Biol_repl_4,0.534670605313399,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,,,
GF2025_P1_Adh,0.5153517655518619,0.41487055329718353,
GF2025_P1_Sph,0.5830918514063265,0.458394794354206,
EJN2021_5_Ex_Basal,0.5249655833568215,,
HS2024_7_I_T3,0.5310072457078115,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.5210196196418685,0.4365389812570907,
CF2017_EOC 1,0.5247120297516877,,
CK2022_3 200-1,0.5250045414536384,,
AH2018_LFQ_IT_3_C,0.5320012469552614,0.4396145331599897,
SR2019_Hs578T_Biol_repl_2,0.531458169542114,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,0.5365573840419694,,
HS2024_5_B_T1,0.5072921800630076,0.44325802369286066,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,0.5353240376754268,,
HS2024_3_B_T2,0.5051850216724149,,
RB2022_6_PreStrength,,,
CK2022_2 40-1,,,
RB2022_1_PostSprint,0.5279885402429725,,
CK2022_4 200-1,0.5243203043120908,,
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,,,
AR2021_ALG 1 μM,0.5478109860911582,,
HS2024_4_B_T1,0.5237298537768227,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,0.5260967264818691,,
EJN2021_1_Rest_Basal,0.5290368136401954,,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,0.4827148624289636,0.3986692434389712,
CK2022_9 16-1,,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,0.5187758752681084,,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,,,
CK2022_16 16-1,,,
FS2019_db/db3,,,
CK2022_15 40-1,,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.5239247139392885,0.43652563181710935,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,,,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,0.5345209790476811,0.4427837807530765,
HS2024_5_PD_T3,0.49376130656007117,,
AH2018_TMTMS3_3_X,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,,0.44481796164702414,
AH2018_LFQ_M_1_N,0.5295238600249262,0.44881720810259385,
KBE2022_Log2_Ex_27_U,0.5192670498112754,0.4343168494290363,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,0.5291502830514165,0.44611543467289666,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,0.54371307429929,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,,,
YA2020_Reporter_intensity_Normal_No.4,,0.44510997099530725,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,,,
RN2012_L13,0.5085809718483397,,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,,0.4313345760308424,
SR2019_SKBR3_Biol_repl_3,0.5431514806199446,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,0.5627116535626656,,0.6733542783547369
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,0.5288939395690417,,
HS2024_6_I_T2,0.5169365021480152,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,0.554494672863216,0.37155558515259807,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,0.5449047668661989,,
LY2019_P3+,0.5043982724179991,,
HH2022_Reporter intensity 6,,,
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,0.5424415602356507,,
AH2018_TMTMS2_3_X,,,
GF2025_P3_Adh,0.5498415862794085,0.42182073331747977,
SR2019_JIMT1_Biol_repl_2,0.5287820119410642,,
AH2018_TMTMS2_1_C,,,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,0.5337288665832405,,
KBE2022_Log2_Ex_19_U,,0.439336917830225,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,0.5544261968144687,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,,0.44421477192351827,
AST2020_Control,,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,0.5561090886693479,0.432677313010908,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,0.5450959238892233,,
RB2022_7_RecoverySprint,,,
YA2020_Reporter_intensity_Normal_No.3,,0.4391593169340169,
HS2024_8_B_T2,0.5624619551721081,0.447314189688295,
AH2018_LFQ_1_X,,0.43058230347052,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,0.52112632547099,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,,,
HH2022_Reporter intensity 1,,0.43161708924025266,
HH2022_Reporter intensity 2,,0.4307372541570706,
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,,0.4342255423614107,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,0.5620847695263983,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,0.571477690161121,,
SR2019_LM2_Biol_repl_3,0.5341849157439172,,
RB2022_4_RecoveryStrength,0.54463420476301,,
CR2017_Ratio Replicate 2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,0.5604674257662942,0.4103352474449406,
AR2021_KD 72h,0.5030393187873132,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,0.5179304889402999,0.4362730664996549,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,,,
KBE2022_Log2_Ex_9_U,0.5244805314890396,0.4436352565892666,
AH2018_SILAC_M_3_N,0.5252989173216968,0.4269519197499899,
KBE2022_Log2_Ex_13_T,,0.4410879447167761,
RM2024_Intensity D0-3,0.5322268494511132,,
SR2019_SKBR3_Biol_repl_1,0.547318906129786,,
PG2020_Intensity Mock_10h_C,,,
CF2017_OSE 29,0.5274965277872077,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,,
HS2024_7_B_N2,0.5173737813183182,,
PG2020_Intensity 10h_A,,,
RN2012_L12,0.5482103009437747,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,0.5208947428019387,0.4129408888934069,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,0.5238913294794495,,
FSO2013_Ratio H/M normalized Rep1___1,0.5508598298294882,0.4115187508479745,
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,,,
RB2022_7_RecoveryEndurance,,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,0.5246409808273683,,
TM2022_S2.12h.B,,,
RN2012_L15,0.542533150208068,0.45240755089313406,0.6942984901520046
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,,,
FSO2013_Ratio H/M normalized Rep2___2,0.5475076058230801,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,,,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,,,
RB2022_1_PreSprint,0.5201715690424348,,
HS2024_4_I_N1,0.5665327092113106,0.4706588167550891,
CK2022_7 200-1,0.5184018543139044,,
CK2022_5 200-1,0.5192833310239818,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,0.5120516828348252,0.40545593851345935,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,,,
AH2018_SILAC_MR_1_X,0.5283672702587153,0.4305040469471916,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,0.5430088406363648,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,,,
AH2018_SILAC_3_C,0.5209494561525317,0.4130566906908795,
EJN2021_5_Rest_Ins,0.5331565736930096,,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,0.5617541242884386,0.40871997827736883,
CK2022_4 16-1,,,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,0.534889540558959,,
EJN2021_2_Ex_Ins,0.5302762371878895,,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,0.5270416402738535,0.44107366603697507,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,,
FSO2013_Ratio H/L normalized Rep3,0.5094483923809584,0.39690136569037887,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,0.5296119965518159,,
KBE2022_Log2_Ex_9_T,0.5231697704394711,0.43900581440783765,
AH2018_SILAC_IT_2_N,0.5208218399957268,0.43494456637524526,
AH2018_SILAC_IT_1_X,0.5327462146496257,0.4444173810188919,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,0.5428604124866582,,
UK2020_UA_2,0.537872836373423,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,0.5921040001541232,0.4687931016960762,
WZ2023_Pe_025_20min,0.519395796206995,0.4347684319510118,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,0.5291016038799138,0.4426774682171533,
HS2024_4_I_N2,0.5058515389937782,0.436243568130905,
AH2018_TMTMS2_3_N,,,
RN2012_H06,0.5306699136324845,0.44785818649242587,0.6628915049106573
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,0.5087664784164334,,
WZ2023_Su_005_30min,0.5269897409224195,0.43909344092329566,
SR2019_HCC1419_Biol_repl_4,0.5450696736470091,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,0.5381188063400751,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,,,
WZ2023_Su_025_10min,0.5250121399037709,0.43475222669834274,
AH2018_LFQ_IT_4_X,0.5250080052336764,0.4287096124612685,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,0.5391970158705119,,
RM2024_Intensity D6-3,0.5417498756425834,,
WZ2023_Su_005_20min,0.527271470976091,0.43632299177334444,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,0.5528298788790709,,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,,,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,,,
LY2019_P7+,,,
EP2017_Untreated R#1 normalized log2 ratio,0.5416389510769501,,
RN2012_L10,0.535628632008356,,
PG2020_Intensity 4h_C,,,
EP2017_Mitotic R#3 normalized log2 ratio,0.5307760818317288,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,,,
RB2022_8_PostStrength,0.5267329874152841,,
AH2018_SILAC_IT_2_X,0.5346200942390323,0.44705190008953843,
HS2024_4_B_T3,0.5145759742015131,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,0.49574792623028635,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,0.5532655478099527,,
KBE2022_Log2_Ex_6_U,0.5200302207328961,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.5195299415007694,,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5242536549583686,,
GF2025_P9_Sph,0.582796608314807,0.468055658180948,
CK2022_6 200-1,0.5193319012667502,,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,,,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,,,
HS2024_4_I_T2,0.5160627214106303,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,0.5292557629232214,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,0.5438643436480884,,
HS2024_3_B_T3,0.5276145070702881,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,0.5355384269488844,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,,,
EP2017_Untreated R#3 normalized log2 ratio,0.5069936388145236,,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,0.518922606881725,,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,,,
RB2022_7_PostEndurance,,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5449675889401596,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,0.5320394221029331,0.43960147053254955,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,0.505620003551117,,
KBE2022_Log2_Ex_29_T,0.525829097396998,0.43765718663034126,
HS2024_7_I_T2,0.5422254964886973,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,0.5074802301423337,,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,0.5220597325829253,,
FR2021_Intensity.M,0.52112632547099,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,0.5336279267888694,0.4305122671110962,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,0.5172016581192059,,
PG2020_Intensity CT_C,,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,0.5247862305394824,,
EP2017_Untreated R#3 log2 ratio,0.5060992601759208,,
RB2022_2_PostStrength,,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,,,
HS2024_8_PD_T2,0.5402291751018289,0.4323938392178663,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,,
FR2021_Norm.Intensity.G,0.5281400092393963,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,0.5433932820005699,,
HS2024_8_B_N1,0.5422614841801477,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,0.5245156270320589,,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,,,
CR2017_Ratio Replicate 2.3,,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,0.5170995441478883,0.4082946427157353,
YA2020_Reporter_intensity_Normal_No.2,,0.437765945511784,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,0.5423276892271045,,
HS2024_3_PD_T3,0.5386203439723741,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,0.5296250391808451,,
RAM2015_Log2 C,,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,0.5315207789595746,0.44856046138972416,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,,0.44258466449150446,
CK2022_2 16-1,,,
RAM2015_Log2 B,,,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,0.5158426541899394,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,0.5225489365921226,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,0.5165736171572759,,
UK2020_HCM_5,0.5386508190162415,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,,
HS2024_7_PD_T3,0.546200158721818,,
PG2020_Intensity Mock_10h_B,,,
WZ2023_Su_025_30min,0.5242512612827491,0.4457739405149382,
AH2018_LFQ_4_N,0.5295024192077562,0.42718135591011835,
CR2017_Ratio Replicate 1.2,,,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,0.5124375291822076,,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,,,
AH2018_SILAC_M_1_X,0.5294663612038784,0.44263269517893544,
RB2022_7_PreEndurance,,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,,,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,0.5077238608089341,0.4129839021480625,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,0.5442917843989873,0.4681111719481038,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,,,
SR2019_Hs578T_Biol_repl_4,0.5315177942527743,,
RB2022_8_PreStrength,0.5224876585195276,,
KS2014_Intensity C5,,,
RM2024_Intensity D0-1,0.5307873312770423,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,0.49610782766085754,0.4191175218774652,
RB2022_3_PostStrength,0.5673454728177711,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,0.5135969649816534,,
SR2019_BT549_Biol_repl_1,0.5202628121341059,,
AH2018_LFQ_M_4_N,0.5319729463904149,0.4380409159040371,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,,
AH2018_LFQ_2_X,,0.4088943729817938,
PG2020_Intensity 2h_B,,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,0.5490221819642446,,
KS2014_Intensity E15_3,,,
GF2025_P3_Sph,0.5771579517817943,0.4133838181267735,
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,0.5265336982804444,0.4310855536874283,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,0.5680353772933392,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.5286971103481547,,0.6777792126776193
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,0.5169503527517704,0.4194994047103746,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,0.5190814100829453,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,,,
ZQ2022_N1,0.5305483451138295,,
LY2019_P6-,,,
RM2024_Intensity D2-3,0.5359220842000848,,
UK2020_HCM_1,0.5393032155685985,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,0.5329336287198563,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,0.5117174031501682,0.44382571054929726,0.6515256454761968
AH2018_LFQ_3_N,0.517074653810905,0.42137426749295587,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,,,
UK2020_UA_1,0.5384327315825964,,
KBE2022_Log2_Ex_13_U,,0.43358604800681466,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,0.5445236816770146,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,,,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,,
SR2019_BT549_Biol_repl_2,0.5219651302859857,,
RM2024_Intensity D4-2,0.5387530579761967,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,0.5265855530301522,,
HS2024_5_PD_T2,0.5321446438192055,,
WZ2023_Su_025_20min,0.5245011315497732,0.4196553411458333,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,0.5437119937740441,,
LY2019_P8-,,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,0.49011404748881365,0.4699301066006584,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,0.5397235196775815,,
PG2020_Intensity 10h_D,,,
RB2022_8_PreEndurance,,,
HS2024_3_B_N2,0.5017592023033681,,
EJN2021_4_Ex_Ins,0.5207329892594728,,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,0.5288086999851161,,
EP2017_Pervanadate R#3 log2 ratio,0.5477773015530025,,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,,,
AH2018_SILAC_MR_3_C,0.5317647092206289,0.436440571179353,
AH2018_LFQ_M_4_C,0.5244571387554268,0.43853301002920386,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,0.5412589732722267,,
CK2022_6 40-1,,,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,0.5229070292965214,,
LY2019_P3-,0.5044325366460286,,
FR2021_Intensity.A,0.5211111829646723,,
EJN2021_3_Ex_Ins,0.5215967069527939,,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.5176912904043728,0.4373227531410399,
HS2024_8_PD_T3,0.5560633270892816,0.4700523689865577,
EJN2021_3_Ex_Basal,0.5236513053840354,,
AST2020_Control.1,,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.520211185362814,0.41612451794498334,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,0.5094435948573435,0.40864038307496003,
RB2022_1_RecoveryStrength,0.5280778691076183,,
SR2019_HCC1954_Biol_repl_4,0.543264208100262,,
FR2021_Norm.Intensity.N,0.5242786491296674,,
HS2024_5_B_N1,0.554050128454025,,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,,,
RB2022_4_PreSprint,0.52729835853148,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,,,
HS2024_8_I_N2,0.5086568752598327,,
RB2022_3_RecoveryStrength,,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,0.5293387278298641,0.44070580010251115,
LY2019_P8+,,,
RB2022_2_RecoveryEndurance,,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,0.5416686207894693,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,0.5362014704740923,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.5255926108845693,,0.6816620182442632
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,0.522510428460623,0.44225218417948803,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,0.5290594832317431,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,0.5231939021172659,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,0.5323892424469984,,
LY2019_P2-,0.5252177377042255,,
AH2018_LFQ_IT_1_X,0.5281064562594149,0.43856389404469603,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,0.513065486339047,,
WZ2023_Pe_005_20min,0.5175524553323693,0.4336797468111967,
AST2020_Control.2,,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,0.5567926621592042,,0.6430044460081719
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,,,
SR2019_MCF10A_Biol_repl_4,0.5372805118931162,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,0.5405212328088812,,
HS2024_5_B_T2,0.5326545714009897,0.4445931803235011,
HS2024_6_I_T1,0.5216242399714709,,
HS2024_5_B_T3,0.517205442677109,0.44742425616573483,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,0.5212322565132642,0.4369667176536368,
AH2018_TMTMS3_3_N,,,
SR2019_HCC1419_Biol_repl_2,0.5467959534422233,,
FR2021_Intensity.N,0.5242568570279422,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,0.5174527138982735,0.43231716047888974,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,0.5321961748620953,,
KBE2022_Log2_Ex_36_T,0.5208173905408864,0.4372502206790926,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.5249894796554132,0.4330446579385601,
KS2014_Intensity C2,,,
FSO2013_Ratio H/L normalized Rep1___2,0.5139303706763846,,
RM2024_Intensity D2-2,0.5374420975549511,,
KBE2022_Log2_Ex_42_T,0.5203281518503581,,
CK2022_9 200-1,0.5236801918805646,,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,0.5242037007811701,,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,0.5469281623270269,0.4203268995221488,
RBK2021_1332T Late,,,
LY2019_P1-,0.5499439690752144,,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,,,
HS2024_3_I_T3,0.546934062429314,,0.7076207245785179
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,,,
ZQ2022_C3,0.5253942811736411,,
EJN2021_3_Rest_Ins,0.5275093799302661,,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,0.5265335647959464,,
FSO2013_Ratio H/M normalized Rep3___2,0.5505283898387323,,
RM2024_Intensity D6-2,0.5410901768082969,,
EP2017_Untreated R#1 log2 ratio,0.540679635985759,,
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,0.5391616988594344,,
WZ2023_Pu_010_10min,0.5158655180066959,0.4341910368135514,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,0.5424618146626173,,
HS2024_5_I_T3,0.5496176425054031,0.48977673095669017,
KS2014_Intensity N1,,,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,0.5356294757455319,0.4270474943806417,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,0.5217395525879005,0.4263598823149094,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,0.5419834953777177,,
HS2024_5_B_N2,0.4839353712564214,,
HS2024_5_I_N1,0.5038011524144712,,
HS2024_6_I_N1,0.5349467223428167,,
AR2021_KD 48h,0.4897154100736472,,
FR2021_Intensity.B,0.5276483803459184,,
RB2022_3_PreEndurance,,,
HS2024_5_I_T1,0.5091960585879737,0.44202351937004175,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,0.5334817867727456,,
AST2020_anti-CD3,,,
SR2019_MDAMB231_Biol_repl_1,0.5359509204271146,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.5217107203840338,0.4271191808596571,
KBE2022_Log2_Ex_29_U,0.5248927662624582,0.44220607773569387,
HS2024_7_B_T1,0.5364832126359984,,
AH2018_LFQ_M_2_X,,0.4108871881278997,
AH2018_LFQ_IT_4_N,0.5244090586453044,0.42492888456552463,
CK2022_15 200-1,0.5191173236952836,,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,0.5403926797006582,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,0.5242138062128981,,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.5223898117753563,0.4245019189654106,
RN2012_H01,0.5315292509214121,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,0.5298005102173966,,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5531385844708768,,
HS2024_8_B_T3,0.5644422661571146,,
YA2020_Reporter_intensity_Cancer_No.3,,0.439383188946601,
KBE2022_Log2_Ex_44_U,,,
WZ2023_Pe_010_20min,0.5217463947605429,0.4401438431752263,
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,,,
FSO2013_Ratio H/M normalized Rep3___1,0.5404781790700327,0.4107845282634974,
AH2018_SILAC_M_3_C,0.5220989960055628,0.41611419339297434,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,0.5324246525841669,0.44035384674932726,
AH2018_SILAC_M_2_X,0.5340492104225324,0.44205906130025546,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,0.5227583510807983,,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.5241692368854297,0.4266228566938319,
PG2020_Intensity 6h_C,,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,0.5215118258828515,0.432829898558661,
VOI2024_0.1uM 24 h_2 mono,,0.43921403480076204,
AH2018_TMTMS2_3_C,,,
CK2022_15 16-1,,,
CK2022_3 16-1,,,
LY2019_P4-,0.5219559067134442,,
FSO2013_Ratio H/L normalized Rep3___2,0.5237657476489198,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,0.4984077264400009,,
GF2025_P8_Adh,0.5087703964982281,0.4149353279621045,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,0.570622774187188,0.4732199218977731,
CK2022_10 16-1,,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.5327671989784798,,0.6614692974472096
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,0.5388235351684164,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,0.541013259972165,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,0.5250643206871414,,
EJN2021_2_Ex_Basal,0.5224253418045312,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,0.5232533860828608,,
AR2021_L41 10 μM,0.5318494672456829,,
CF2017_EOC 2,0.5221156238867292,,
RB2022_6_PostEndurance,,,
AH2018_SILAC_1_N,0.5272504157418624,0.4413607631481703,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,0.5378445960696155,,
RB2022_7_PreSprint,,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,0.5225853403813954,,
CK2022_6 16-1,,,
ZX2022_CB treated Replicate 1,0.5472123397559207,,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,,0.4321616064924468,
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,0.5143580825556797,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,,,
AR2021_L41 1 μM,0.5467905399687712,,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,,,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,0.5458450480054932,,
KS2014_Intensity C4,,,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,0.5179061290594763,0.4352550785980124,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,0.5384091335928227,,
HS2024_7_B_T2,0.526068288822234,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,0.515416596112016,0.4378170849615065,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,,0.4422127010566137,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,0.5103814042145007,,
AH2018_SILAC_IT_3_C,0.5329268732231272,0.43377738540408695,
WZ2023_Pu_025_10min,0.5253968385099613,0.4511605195895333,
RM2024_Intensity D2-2___3,0.5341702355321948,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,0.5610775393222193,0.4488713799193916,
SR2019_JIMT1_Biol_repl_4,0.5329342061585179,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,0.5391268524761029,,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.5204353509996335,0.43511781631448493,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,0.5368708983063133,0.4419251509940569,
KS2014_Intensity C6,,,
ZQ2022_N3,0.5339204070305708,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,0.5478314291612763,,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,,,
AH2018_SILAC_IT_2_C,0.5274868033112492,0.4317544957831286,
CK2022_5 40-1,,,
AH2018_LFQ_3_X,,0.4282460005629364,
UK2020_UA_3,0.5373359302756199,,
LY2019_P7-,,,
GF2025_P5_Adh,0.4975033904562276,0.41934773842804757,
RB2022_1_PostStrength,0.530539564548695,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,0.517576425742332,0.3965871254885433,
SR2019_HCC1954_Biol_repl_3,0.5419416841151105,,
CR2017_Ratio Replicate 2.2,,,
VOI2024_0.1uM 2 h_1 mono,,0.4138461150624157,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,,,
ZQ2022_C1,0.531531256070013,,
CR2017_Ratio Replicate 2.1,,,
PG2020_Intensity CT_B,,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,0.5407692430608728,0.45005393979908737,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),0.5281287405239484,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,,0.4333916035128783,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,0.5198745591320625,0.434186210996278,
YA2020_Reporter_intensity_Cancer_No.4,,0.44381893291705216,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,0.5515640593175992,0.43898616824653935,
RB2022_2_PreEndurance,,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,0.5123434231799769,,
CK2022_14 16-1,,,
AST2020_anti-CD3+PDL2,,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,,0.434046065723613,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,0.5424451436109947,,
HS2024_8_I_T1,0.5351748769854193,0.4265126812605057,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),0.5352917550000821,,
EP2017_Mitotic R#2 log2 ratio,0.5223094251432953,,
AH2018_TMTMS2_1_X,,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,0.523204864365962,,
HS2024_6_I_N2,0.5338021217923897,,
HH2022_Reporter intensity 4,,0.4380576265103938,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,0.539190813637788,,
HS2024_4_I_T3,0.5392702182171721,,
AH2018_SILAC_1_X,0.5281378814095041,0.43866918003565614,
PG2020_Intensity 10h_B,,,
AH2018_TMTMS3_1_X,,,
CF2017_FTE 14,0.5171412017293587,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,0.5394721901364936,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,,,
SR2019_HCC1419_Biol_repl_3,0.5450497524638257,,
KBE2022_Log2_Ex_14_T,,0.4300650371932559,
EP2017_Untreated R#2 normalized log2 ratio,0.572695756649391,,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,,,
HS2024_5_I_N2,0.5103950699301183,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,0.544366916793901,,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
